IL205181A0 - Compounds for inhibiting ksp kinesin activity - Google Patents

Compounds for inhibiting ksp kinesin activity

Info

Publication number
IL205181A0
IL205181A0 IL205181A IL20518110A IL205181A0 IL 205181 A0 IL205181 A0 IL 205181A0 IL 205181 A IL205181 A IL 205181A IL 20518110 A IL20518110 A IL 20518110A IL 205181 A0 IL205181 A0 IL 205181A0
Authority
IL
Israel
Prior art keywords
compounds
ksp kinesin
kinesin activity
inhibiting ksp
inhibiting
Prior art date
Application number
IL205181A
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40254344&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL205181(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL205181A0 publication Critical patent/IL205181A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL205181A 2007-11-09 2010-04-18 Compounds for inhibiting ksp kinesin activity IL205181A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98679907P 2007-11-09 2007-11-09
PCT/US2008/080176 WO2009061596A1 (en) 2007-11-09 2008-10-16 Compounds for inhibiting ksp kinesin activity

Publications (1)

Publication Number Publication Date
IL205181A0 true IL205181A0 (en) 2010-11-30

Family

ID=40254344

Family Applications (1)

Application Number Title Priority Date Filing Date
IL205181A IL205181A0 (en) 2007-11-09 2010-04-18 Compounds for inhibiting ksp kinesin activity

Country Status (14)

Country Link
EP (1) EP2215064A1 (en)
JP (1) JP2011503076A (en)
KR (1) KR20100075508A (en)
CN (1) CN101952255A (en)
AR (1) AR068889A1 (en)
AU (1) AU2008325025A1 (en)
CA (1) CA2702990A1 (en)
CL (1) CL2008003062A1 (en)
IL (1) IL205181A0 (en)
MX (1) MX2010004314A (en)
PE (1) PE20090968A1 (en)
TW (1) TW200922559A (en)
WO (1) WO2009061596A1 (en)
ZA (1) ZA201002700B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0818605A2 (en) * 2007-10-19 2015-04-22 Schering Corp ESP-CONDENSED 1,3,4-TIADIAZL DERIVATIVES TO INHIBIT KINESIMA KSP ACTIVITY
DE102008001932A1 (en) * 2008-05-21 2009-11-26 Bayer Cropscience Ag Substituted spiroisoxazolines
RU2021101430A (en) * 2014-03-20 2021-03-16 Капелла Терапьютикс, Инк. BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR CANCER TREATMENT
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5336470B2 (en) * 1971-08-09 1978-10-03
DE60329990D1 (en) * 2002-03-08 2009-12-24 Merck & Co Inc MITOTIC KINESINE HEMMER
US7449486B2 (en) * 2004-10-19 2008-11-11 Array Biopharma Inc. Mitotic kinesin inhibitors and methods of use thereof
WO2006110390A1 (en) * 2005-04-07 2006-10-19 Merck & Co., Inc. Mitotic kinesin inhibitors

Also Published As

Publication number Publication date
EP2215064A1 (en) 2010-08-11
AR068889A1 (en) 2009-12-16
TW200922559A (en) 2009-06-01
CL2008003062A1 (en) 2010-02-19
JP2011503076A (en) 2011-01-27
PE20090968A1 (en) 2009-07-13
WO2009061596A1 (en) 2009-05-14
ZA201002700B (en) 2010-12-29
MX2010004314A (en) 2010-04-30
AU2008325025A1 (en) 2009-05-14
CN101952255A (en) 2011-01-19
KR20100075508A (en) 2010-07-02
CA2702990A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
IL268511B (en) " system for supply chain management"
IL249525A0 (en) Hydrogen-catalyst reactor
EP2141990A4 (en) 11beta-hsd1 active compounds
IL200548A0 (en) Ppar active compounds
IL200543A0 (en) Ppar active compounds
GB0720038D0 (en) New compounds
IL202620A0 (en) Lantibiotic-based compounds having antimicrobial activity
IL205184A0 (en) Spiro-condensed 1, 3, 4 - thiadiazole derivatives for inhibiting ksp kinesin activity
GB0720503D0 (en) New compound
IL200165A0 (en) Compounds that inhibit cholinesterase
GB0722769D0 (en) New compounds
GB0701273D0 (en) New compounds
GB0705672D0 (en) Compounds
GB2458623B (en) System for the management of arousal levels of a subject
GB0814164D0 (en) Presence management system
HU0700395D0 (en) New compounds
EP2304655A4 (en) Activity based management system
EP2076460A4 (en) Breakdown reel
IL205181A0 (en) Compounds for inhibiting ksp kinesin activity
GB0707034D0 (en) Compounds
ZA201103269B (en) COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
GB0712393D0 (en) Compounds
EP2192904A4 (en) Methods for inhibiting tgf-
ZA201203193B (en) Amidoacetonitrile compounds having pesticidal activity
EP2463292A4 (en) Compound having neurite-outgrowing activity